by admin | Dec 27, 2022 | press-releases
Home PRESS RELEASE CG Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== --> Listen to this article...
by admin | Nov 15, 2022 | press-releases
Home PRESS RELEASE CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER...
by admin | Nov 10, 2022 | press-releases
Home PRESS RELEASE CG Oncology Presents New Phase 2 Data with cretostimogene grenadenorepvec in Combination with pembrolizumab in Non-Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guérin 💻 DESKTOP AUDIO PLAYER =============================== -->...
by admin | Oct 24, 2022 | press-releases
Home PRESS RELEASE CG Oncology to Present New Phase 2 Data with cretostimogene grenadenorepvec in Combination with pembrolizumab in Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin at SITC 2022 Annual Meeting 💻 DESKTOP AUDIO PLAYER...
by admin | Jun 4, 2022 | press-releases
Home PRESS RELEASE CG Oncology Presents New Clinical Data on Two Ongoing Programs at The American Society of Clinical Oncology (ASCO) 2022 Annual Meeting 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER...
by admin | May 16, 2022 | press-releases
Home PRESS RELEASE CG Oncology Presents Additional Phase 2 Data with cretostimogene grenadenorepvec in Combination with pembrolizumab in Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin 💻 DESKTOP AUDIO PLAYER ===============================...